By Iain Gilbert
Date: Friday 30 May 2025
(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.
By Josh White
Date: Monday 13 Jan 2025
(Sharecast News) - Two director share purchases disclosed to the market in London on Monday involved insiders at the Conygar Investment Company and Aptamer Group.
By Iain Gilbert
Date: Thursday 19 Dec 2024
(Sharecast News) - Life sciences group Aptamer has struck a new development contract agreement with a rare disease biopharmaceutical company worth up to £155,000.
Currency | UK Pounds |
Share Price | 0.35p |
Change Today | -0.030p |
% Change | -8.00 % |
52 Week High | 0.85 |
52 Week Low | 0.21 |
Volume | 15,661,631 |
Shares Issued | 1,991.34m |
Market Cap | £6.87m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:58 | 279,343 @ 0.36p |
13:45 | 2,966,504 @ 0.34p |
13:46 | 100,000 @ 0.34p |
13:45 | 1,188,726 @ 0.34p |
13:39 | 1,400,000 @ 0.36p |
CEO | Arron Tolley |
CFO | Andrew Rapson |
You are here: research